| Dr Inga S Johannesson, DO | |
|
193 Main St, Suite 1, Norway, ME 04268-5645 | |
| (207) 330-3950 | |
| (207) 330-3955 |
| Full Name | Dr Inga S Johannesson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 193 Main St, Norway, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205863156 | NPI | - | NPPES |
| 419020099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 1827 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Androscoggin Home Care & Hospice | Lewiston, ME | Hospice |
| Stephens Memorial Hospital | Norway, ME | Hospital |
| St Mary's Regional Medical Center | Lewiston, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
In a paper recently uploaded to the preprint server medRxiv by Garlanda et al. (June 8th, 2021), humoral pattern recognition molecules are explored for affinity towards SARS-CoV-2, contributing to unraveling the role of these molecules in COVID-19 disease progression.
People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.
The STAT transcription factors are involved in the development of many forms of cancer. STAT3 is frequently activated in tumour cells, so drugs targeting STAT3 could be used in cancer therapy. However, STAT3 is also important in the development of the immune system. Dagmar Gotthardt and colleagues at the Vetmeduni Vienna now show that blocking STAT3 in cells of the immune system actually leads to increased anti-tumour immunity. Anti-STAT3 therapy may thus be highly promising.
Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.
BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has provided a donation of implantable cardiac defibrillators and pacemaker device implants to more than 75 low-income and impoverished patients in the Republic of Trinidad & Tobago as part of its collaboration with Heartbeat International Foundation Inc.
› Verified 1 days ago
| Entity Name | Stephens Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346299815 PECOS PAC ID: 8921990193 Enrollment ID: O20040602000734 |
News Archive
In a paper recently uploaded to the preprint server medRxiv by Garlanda et al. (June 8th, 2021), humoral pattern recognition molecules are explored for affinity towards SARS-CoV-2, contributing to unraveling the role of these molecules in COVID-19 disease progression.
People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.
The STAT transcription factors are involved in the development of many forms of cancer. STAT3 is frequently activated in tumour cells, so drugs targeting STAT3 could be used in cancer therapy. However, STAT3 is also important in the development of the immune system. Dagmar Gotthardt and colleagues at the Vetmeduni Vienna now show that blocking STAT3 in cells of the immune system actually leads to increased anti-tumour immunity. Anti-STAT3 therapy may thus be highly promising.
Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.
BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has provided a donation of implantable cardiac defibrillators and pacemaker device implants to more than 75 low-income and impoverished patients in the Republic of Trinidad & Tobago as part of its collaboration with Heartbeat International Foundation Inc.
› Verified 1 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
In a paper recently uploaded to the preprint server medRxiv by Garlanda et al. (June 8th, 2021), humoral pattern recognition molecules are explored for affinity towards SARS-CoV-2, contributing to unraveling the role of these molecules in COVID-19 disease progression.
People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.
The STAT transcription factors are involved in the development of many forms of cancer. STAT3 is frequently activated in tumour cells, so drugs targeting STAT3 could be used in cancer therapy. However, STAT3 is also important in the development of the immune system. Dagmar Gotthardt and colleagues at the Vetmeduni Vienna now show that blocking STAT3 in cells of the immune system actually leads to increased anti-tumour immunity. Anti-STAT3 therapy may thus be highly promising.
Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.
BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has provided a donation of implantable cardiac defibrillators and pacemaker device implants to more than 75 low-income and impoverished patients in the Republic of Trinidad & Tobago as part of its collaboration with Heartbeat International Foundation Inc.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Inga S Johannesson, DO 301c Us Route 1, Scarborough, ME 04074-9701 Ph: (207) 396-8600 | Dr Inga S Johannesson, DO 193 Main St, Suite 1, Norway, ME 04268-5645 Ph: (207) 330-3950 |
News Archive
In a paper recently uploaded to the preprint server medRxiv by Garlanda et al. (June 8th, 2021), humoral pattern recognition molecules are explored for affinity towards SARS-CoV-2, contributing to unraveling the role of these molecules in COVID-19 disease progression.
People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term.
The STAT transcription factors are involved in the development of many forms of cancer. STAT3 is frequently activated in tumour cells, so drugs targeting STAT3 could be used in cancer therapy. However, STAT3 is also important in the development of the immune system. Dagmar Gotthardt and colleagues at the Vetmeduni Vienna now show that blocking STAT3 in cells of the immune system actually leads to increased anti-tumour immunity. Anti-STAT3 therapy may thus be highly promising.
Concentric Pharma Advertising, an independent healthcare advertising and marketing agency, announces the creation of Salix Pharmaceuticals' Hepatic Encephalopathy Living Program. H.E.L.P. launched May 24, 2010, and coincides with the launch of Xifaxan550 (rifaximin) for the management of patients 18 or older at risk for overt hepatic encephalopathy recurrence.
BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has provided a donation of implantable cardiac defibrillators and pacemaker device implants to more than 75 low-income and impoverished patients in the Republic of Trinidad & Tobago as part of its collaboration with Heartbeat International Foundation Inc.
› Verified 1 days ago
Brian Michael Nolan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 193 Main St, Suite 1, Norway, ME 04268 Phone: 207-743-7721 Fax: 207-743-6306 | |
Dr. Peter R Harbage, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 193 Main St, Suite 1, Norway, ME 04268 Phone: 207-743-7721 Fax: 207-743-6306 | |
David James Kumaki, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 193 Main St, Suite 1, Norway, ME 04268 Phone: 207-743-7721 Fax: 207-743-6306 | |
Dr. Sarah Mulligan Wilson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 193 Main St, Norway, ME 04268 Phone: 207-662-7060 | |
Francis X Kieliszek, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 193 Main St, Suite 1, Norway, ME 04268 Phone: 207-743-7721 Fax: 207-743-6306 | |
Dr. Samuel James Ferguson, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Pikes Hl, Norway, ME 04268 Phone: 207-744-6444 |